Hypocholesterolemic substituted 2-azetidinone compounds of the formula:
##STR1##
are disclosed, as well as a methods of lowering cholesterol by administering
said compounds, pharmaceutical compositions containing them, and the combination
of a substituted 2-azetidinone cholesterol-lowering agent and a cholesterol biosynthesis
inhibitor for the treatment and prevention of atherosclerosis.